Some Chinese and Hong Kong ventures have deeply invested in the RISC-V open standard chip architecture. DeepComputing, ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...